EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Drug-Induced Liver Injury due to Biologics and Immune Check Point Inhibitors

Fernando Bessone, Einar S Björnsson

Medical Clinics of North America · 2023

DOI: 10.1016/j.mcna.2022.12.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Clinics of North America, 2023. Verfasst von Fernando Bessone und 1 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Médicas, Hospital Provincial del Centenario, University of Rosario, School of Medicine, Urquiza 3101, Rosario 2000, Argentina. E…. Hauptthemen laut MEDLINE: Antirheumatic Agents, Biological Products, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological agents have in the last two decades become very important therapeutic agents, particularly for the treatment of various autoimmune disorders. The most widely used biologics are the tumor necrosis factor-α (TNF-α) receptor antagonists: infliximab, adalimumab, and etanercept. Other commonly used biological agents are interleukin (IL)-1 receptor antagonist (Anakinra), interleukin (IL)-6 receptor antagonist (tocilizumab), and CD20 surface antigen antagonist (rituximab). The current review will however focus on TNF-α receptor antagonists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsBiological ProductsChemical and Drug Induced Liver InjuryHumansAntibodies, MonoclonalTumor Necrosis Factor-alphaEtanerceptInfliximabAdalimumabInterleukin 1 Receptor Antagonist ProteinReceptors, Tumor Necrosis Factor

Stichwörter der Autor:innen

BiologicsCheckpoint inhibitorsDrug-induced liver injuryHepatitisHepatotoxicity

Substanzen

Antirheumatic AgentsAntibodies, MonoclonalTumor Necrosis Factor-alphaBiological ProductsEtanerceptInfliximabAdalimumabInterleukin 1 Receptor Antagonist ProteinReceptors, Tumor Necrosis Factor

Autor:innen und Institutionen

  • Facultad de Ciencias Médicas, Hospital Provincial del Centenario, University of Rosario, School of Medicine, Urquiza 3101, Rosario 2000, Argentina. Electronic address: bessonefernando@gmail.com.
  • University of Iceland, Hringbraut 101, Reykjavik, Iceland; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland.

Zitieren

APA

Bessone, F., & Björnsson, E. S. (2023). Drug-Induced Liver Injury due to Biologics and Immune Check Point Inhibitors. Medical Clinics of North America. https://doi.org/10.1016/j.mcna.2022.12.008

Vancouver

Bessone F, Björnsson ES. Drug-Induced Liver Injury due to Biologics and Immune Check Point Inhibitors. Medical Clinics of North America. 2023. doi:10.1016/j.mcna.2022.12.008

BibTeX
@article{Bessone2023,
  author = {Bessone, Fernando and Björnsson, Einar S},
  title = {Drug-Induced Liver Injury due to Biologics and Immune Check Point Inhibitors},
  journal = {Medical Clinics of North America},
  year = {2023},
  doi = {10.1016/j.mcna.2022.12.008}
}
Kostenlos starten →